Laouénan, C., Marcellin, P., Lapalus, M., Khelifa-Mouri, F., Boyer, N., Zoulim, F., . . . Guedj, J. (2014). Using Pharmacokinetic and Viral Kinetic Modeling To Estimate the Antiviral Effectiveness of Telaprevir, Boceprevir, and Pegylated Interferon during Triple Therapy in Treatment-Experienced Hepatitis C Virus-Infected Cirrhotic Patients. American Society for Microbiology.
Chicago ZitierstilLaouénan, Cédric, et al. Using Pharmacokinetic and Viral Kinetic Modeling To Estimate the Antiviral Effectiveness of Telaprevir, Boceprevir, and Pegylated Interferon During Triple Therapy in Treatment-Experienced Hepatitis C Virus-Infected Cirrhotic Patients. American Society for Microbiology, 2014.
MLA ZitierstilLaouénan, Cédric, et al. Using Pharmacokinetic and Viral Kinetic Modeling To Estimate the Antiviral Effectiveness of Telaprevir, Boceprevir, and Pegylated Interferon During Triple Therapy in Treatment-Experienced Hepatitis C Virus-Infected Cirrhotic Patients. American Society for Microbiology, 2014.